Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Retinal Diseases

• Pre-operative Vabysmo in Patients With Non-clearing Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy
• Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity
• Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)
• A Study of PER-001 in Participants With Diabetic Retinopathy
• Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
• Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
• Sterilizing Eye Solution to Improve Patient Comfort
• Evaluate the Efficacy of IRX-101 in Reducing Post-Intravitreal Injection Pain and Corneal Epitheliopathy
• Safety and Tolerability of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
• A Dosing Study of Intravitreal Bevacizumab for Retinopathy of Prematurity
• Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity
• Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy
• Safety and Efficacy of Faricimab in Patients With NPDR
• Low Dose Fluorescein Angiography Comparing 1mL and 3mL of 10% Fluorescein
• Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy
• Effect of Topical Antioxidants in Dry Eye Disease and Diabetic Retinopathy
• OTT166 in Diabetic Retinopathy (DR)
• Safety and Tolerability of VGR-R01 in Patients With Bietti Crystalline Dystrophy
• Phase 2 Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Non-proliferative Diabetic Retinopathy
• Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants
• Phacoemulsification Combined With Intravitreal Injection of Ranibizumab Prevent Postoperative Capillary Non-perfusion Zone Progress in Non-proliferative Diabetic Retinopathy
• Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)
• Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy
• Effect of SGLT2i on Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
• A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy
• Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)
• Effectiveness of Periocular Drug Injection in CATaract Surgery
• Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Advanced Vision Loss (Sirius)
• A Study on the Treatment Strategy of NVG Secondary to PDR
• Intravitreal ERT to Prevent Retinal Disease Progression in Children With CLN2
• Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During Operation
• Treating Early Stage Diabetic Retinopathy
• Bromfenac Sodium Hydrate Eye Drops in Familial Exudative Vitreoretinopathy
• A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Participants With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy (NPDR)
• Efficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening
• A Study to Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Retinopathy (CAPRI)
• Ranibizumab Vs Bevacizumab for Type 1 Retinopathy of Prematurity
• Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy
• A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment
• Clonidine as Pain Relief During ROP Eye Examinations
• Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume
• Mother Milk as a Eye Drop & Premature Retinopathy
• An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene.
• A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy, DR)
• Non-proliferative Diabetic Retinopathy Treated With Runcaciguat
• The Gene Replacement Therapy by rAAV2/8-hCYP4V2
• Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial
• Evaluation of the Retina in Patients With Non-proliferative Diabetic Retinopathy After Aflibercept Injection in the Eye
• Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy
• A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration
• Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy
• Fenofibrate for Prevention of DR Worsening
• A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Dry Age-related Macular Degeneration
• A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP
• Bevacizumab Treatment For Posterior Zone I ROP
• Efficacy and Safety of Mydriatic Microdrops Compared With Standard Drops for Retinopathy of Prematurity (ROP) Screening: a Pilot Randomized Clinical Trial
• PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity
• RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) Without Center Involved-Diabetic Macular Edema (CI-DME)
• Study to Evaluate Clinical Efficacy and Safety of Nuvastatic™ - C5OSEW5050ESA in Diabetic Retinopathy.
• Sleep, Diabetic Retinopathy and Melatonin
• Oral Metformin for Treatment of ABCA4 Retinopathy
• Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy
• INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study
• A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Com
• Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema
• HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia
• DEXTENZA VS. PREDNISOLONE ACETATE 1% Macular Edema With Diabetic Retinopathy After Cataract Surgery
• Safety and Efficacy of Zuretinol Acetate in Subjects With Inherited Retinal Disease
• Using Calcium Dobesilate to Treat Chinese Patients With Mild to Moderate Non-proliferative Diabetic Retinopathy
• A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy
• Fasudil Eye Drop in Retinopathy Of Prematurity(ROP)
• MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
• Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients
• A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
• Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
• Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
• Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity
• Combined Antioxidant Therapy on Oxidative Stress in Aqueous and Vitreous Humor of Diabetic Retinopathy Patients
• Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma
• Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME
• Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090
• Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy
• The Effect of Combination of Vitamin A, Vitamin E, Sodium Hyaluronate 0.15% Eye Drop Compared With Sodium Hyaluronate 0.1% Eye Drop to Tear Film Stability and Conjunctival Goblet Cells Density in Patient With Non-Proliferative Diabetic Retinopathy (
• A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon®
• A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
• Extension Study to Study PQ-110-001 (NCT03140969)
• Single Ascending Dose Study in Participants With LCA10
• PRP vs PRP+IVC for Severe nPDR
• Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO
• Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene
• Nutraceutical Support With Omega-3
• Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy
• Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement
• Day Regimes of CONbercept on CytokinEs of PDR Patients Undergoing Vitrectomy - Trial (CONCEPT)
• Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm
• Multicenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR)
• Lowering Events in Non-proliferative Retinopathy in Scotland
• Intravitreal Conbercept After Vitrectomy
• PROMINENT-Eye Ancillary Study (Protocol AD)
• Effect of Vitamin E for Prevention of Retinopathy of Prematurity: A Randomized Clinical Trial.
• A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated.
• Steroids for Early Treatment of Radiation Retinopathy
• The TIME-2b Study: A Study of AKB-9778, a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)
• Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema
• Effects of Early Vitamin A Supplementation on the Risk for Retinopathy of Prematurity in Extremely Preterm Infants
• VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP
• Intravitreal Aflibercept Injection for Radiation Retinopathy Trial
• Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity
• The Efficacy of Intravitreal Aflibercept Injection in Improvement of Retinal Nonperfusion in Diabetic Retinopathy
• Oral Propranolol Improve Retinopathy of Prematurity Outcomes in Very Preterm Infants
• Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH
• Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy
• CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea
• Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDR
• Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy
• Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy
• Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy
• Ocular Discomfort Assessment After Intravitreal Injections
• Infant-parent Skin-to-skin Contact During Screening for Retinopathy
• A Fatty Acids Study in Preventing Retinopathy of Prematurity
• Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy
• A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR
• Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy
• Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
• PRP vs Bevacizumab for PDR Treatment
• Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases
• A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR
• Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema
• Rainbow Extension Study
• Anti-VEGF Treatment for Prevention of PDR/DME
• Evaluation of Treatment of High riSk proLiferative Diabetic retinopathY With Intravitreal Aflibercept injectioN
• Comparison of Interval Variation and Dosage in Preoperative Bevacizumab and Ziv-Aflibercept Administration in Proliferative Diabetic Retinopathy Undergoing Vitrectomy
• Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens
• Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab
• Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD
• Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)
• Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
• Omega-3 LCPUFA Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity
• Study of Topical Ocular PAN-90806 in PDR
• 25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial
• A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy
• Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO)
• Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
• Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy
• Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)
• RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
• X-82 to Treat Age-related Macular Degeneration
• 25-Gauge Vitrectomy With Ranibizumab or Triamcinolone Acetonide on Proliferative Diabetic Retinopathy in China
• Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy.
• Noctura400 Treatment for Diabetic Retinopathy (CANDLE)
• Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I
• Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease
• Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration
• Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.
• Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients
• Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema
• Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy
• Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
• Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature
• PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic Retinopathy
• Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery
• Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy
• Anesthesia for Retinopathy of Prematurity
• Inositol to Reduce Retinopathy of Prematurity
• Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With Hig
• Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes
• Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy
• Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy
• The Efficacy of Paracetamol in Reducing Pain During Ophthalmological Examination for Retinopathy of Prematurity: a Prospective Randomised Trial
• Nepafenac Once Daily for Macular Edema - Study 2
• Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X
• Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy
• Nepafenac Once Daily for Macular Edema - Study 1
• Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage
• Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
• Aflibercept Injection for Proliferative Diabetic Retinopathy
• Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
• Squalamine for the Treatment in Proliferative Diabetic Retinopathy
• Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy
• Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy
• Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy
• Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion
• Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
• Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy
• Topical Betaxolol for the Prevention of Retinopathy of Prematurity
• Causes of Visual Loss in Retinal Disease
• Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE)
• Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
• A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy
• A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP)
• Finasteride for Chronic Central Serous Chorioretinopathy
• Intravitreal Aflibercept Injection for Radiation Retinopathy
• Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
• Registration and Treatment of Pain During Eye Examination of Prematurity
• GW824575 First Time in Human
• Propranolol for Diabetic Retinopathy
• Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
• Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema
• Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED)
• Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
• Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma
• Topical Interferon Gamma-1b for Central Serous Chorioretinopathy
• Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa
• Effect of Doxium on High Sensitivity CRP and Endothelin-1 Serum Levels in Patients With Diabetic Retinopathy
• Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy
• High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy
• The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
• Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
• Diabetic Retinopathy Sulodexide Study
• Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.
• Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferativ
• Avastin for PDR (Proliferative Diabetic Retinopathy)
• Proparacaine and Mydriatic Eye Drops
• Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
• Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective Study
• Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
• Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
• Topical Application of Latanoprost in Diabetic Retinopathy
• Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)
• Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy
• High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
• Ranibizumab for Diabetic Traction Retinal Detachment
• Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy
• Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy
• A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema
• IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
• Rituximab for Autoimmune Retinopathy
• Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity
• Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery
• Study on Effective Mydriasis in Premature Infants
• Efficacy of PreOperative Bevacizumab for Diabetic Eye Disease
• Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy
• Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)
• Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)
• Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone
• Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy
• Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants
• A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
• Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy
• A Study on Traditional Chinese Medicine (TCM) Comprehensive Protocol of Prevention and Control in Diabetic Retinopathy
• Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema
• Use of Pan-Vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)
• Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
• The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy
• Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
• Effect of Levodopa on Human Multifocal Electroretinogram
• Treatment Of Radiation Retinopathy Trial
• Combined Triple Therapy in Diabetic Retinopathy (DRP)
• Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab
• A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients
• Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab
• Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma
• Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy
• Sirolimus to Treat Diabetic Macular Edema
• Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity
• Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA)
• Effects of Copaxone in the Retinal Function in Diabetic Patients After Panphotocoagulation
• Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II)
• Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
• A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects
• Bevacizumab and Long Acting Gas in Diabetic Vitrectomy
• Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity
• Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
• Pharmacological Intervention in Diabetic Retinopathy
• Ranibizumab for Neovascularization in Sickle Cell Retinopathy
• Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study
• Intravitreal Bevacizumab for Diabetic Retinopathy
• Preoperative Bevacizumab for Vitreous Hemorrhage
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
• Bevacizumab Versus Ranibizumab for Diabetic Retinopathy
• Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)
• Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients
• Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy
• Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy
• Treatment of Refractory Diabetic Macular Edema With Infliximab
• Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)
• Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
• Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema
• Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
• Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
• Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy
• Retinal Blood Flow and Microthrombi in Type 1 Diabetes
• Intravitreal Bevacizumab for Retinal Disorders
• Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
• Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema
• Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial
• Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)
• Intravitreal Bevacizumab Vs Photocoagulation for Proliferative Diabetic Retinopathy
• Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome
• Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity
• The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes
• Diabetic Retinopathy Candesartan Trials
• DIabetic Retinopathy Candesartan Trials.
• DIabetic Retinopathy Candesartan Trials
• Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
• Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
• Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema
• Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
• Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment
• Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients
• Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.
• Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
• Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy
• Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders
• Research Study in Patients With Persistent Macular Edema
• HAT in Eye Complications of Behcet's Disease
• Sorbinil Retinopathy Trial (SRT)
• Early Treatment Diabetic Retinopathy Study (ETDRS)